Correspondence

Zuranolone: ACMD advice

Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about zuranolone.

• From: Advisory Council on the Misuse of Drugs
• Published: 13 August 2025

Documents

ACMD advice on zuranolone (accessible)

HTML

ACMD advice on zuranolone

PDF, 87.7 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Zuranolone is expecting approval in the UK for the treatment of moderate or severe postnatal depression. This letter provides advice on the classification and scheduling of zuranolone.

Published 13 August 2025